Merrimack Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2005
NCT00105976
First Marketed Drug
2015
irinotecan (Camptosar)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Merrimack | Merrimack Pharmaceuticals | Merrimack Pharmaceuticals, Inc.